(Date:11/30/2009)...O, Nov. 30 Dr. Jessica Torrente, A...on University Medical Center in Washington, D.C., ...cific Gamma Imaging (BSGI) in clinical practice as...breast cancer today at the annual meeting of the R... "The purpose of the exhibit was to demonstrate ho...
(Date:11/30/2009)... SEATTLE, Nov. 30 Cell T...ounced today that its new class of platinum-based ...strated a stronger anti-tumor potency and activity...mpounds as well as the ability to overcome cisplat...ere presented in a paper titled "Novel Bis-platinu...
(Date:11/29/2009)...s available in German . , The concept of co...ysics. The most famous example is that of quarks w...ow Prof. Bella Lake from Helmholtz-Zentrum Berlin ...report for the first time an experimental realizat... in a condensed matter system. , The concept of ...
(Date:11/26/2009)...TTE, Ind. - A new generation of ultrasmall transis...tructures called semiconducting nanowires are clos... at IBM, Purdue University and the University of C... learned how to create nanowires with layers of di...atomic level, which is a critical requirement for ...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3...l use of DIO-902 with Atorvastatin, SAN FRANCISCO...otechnology company focused on the development of ...d today that a scientific poster relating,to DIO-9...American Society,for Clinical Pharmacology and The...Orlando. DIO-902 is being studied in Phase 2b clin...
...2008 Vista Partners announced,today that it has u...tion,(Nasdaq: ABMC ) and maintains its twelve mon... Research at Vista Partners stated, "Sales,interna...s lab alliance,which give ABMC,s products exposure... as well. Once the company receives CLIA approval ...
...h 31 Chem Rx,Corporation (OTC Bulletin Board: PMQ...nal pharmacy services, announced today that it has...ncial results and discuss 2008 outlook,that was or...ET. Additional,details about the timing of the 200...g conference call will be forthcoming shortly., A...
Other Biology Technology:DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics 2Vista Partners Updates Coverage; Maintains $3.20 Target Price 2Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results 2Mouse Anti-nicotinic Acetylcholine Receptor Monoclonal Antibody, Unconjugated, Clone 88B from Abcam
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human Kappa / CD19 Antibody, FITC, PE Conjugated from Raybiotech, Inc.
Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience
Biology Products: